Minimally Invasive Surgery in Thymic Malignances.
10.3779/j.issn.1009-3419.2018.04.06
- Author:
Wentao FANG
1
;
Zhitao GU
1
;
Keneng CHEN
2
;
Members of the Chinese Alliance for Research in Thymomas
Author Information
1. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China.
2. Department of Thoracic Surgery, Beijing Cancer Hospital, Beijing 100142, China.
- Collective Name:Members of the Chinese Alliance for Research in Thymomas
- Publication Type:Journal Article
- Keywords:
Minimally invasive surgery;
Thymic malignance;
Video-assisted thoracoscopic surgery
- MeSH:
Humans;
Minimally Invasive Surgical Procedures;
methods;
trends;
Retrospective Studies;
Thymoma;
surgery;
Thymus Neoplasms;
mortality;
pathology;
surgery
- From:
Chinese Journal of Lung Cancer
2018;21(4):269-272
- CountryChina
- Language:Chinese
-
Abstract:
Surgery is the most important therapy for thymic malignances. The last decade has seen increasing adoption of minimally invasive surgery (MIS) for thymectomy. MIS for early stage thymoma patients has been shown to yield similar oncological results while being helpful in minimize surgical trauma, improving postoperative recovery, and reduce incisional pain. Meanwhile, With the advance in surgical techniques, the patients with locally advanced thymic tumors, preoperative induction therapies or recurrent diseases, may also benefit from MIS in selected cases.
